US EditionPublished • loading... • Updated
Globus Medical’s Blockbuster Finish Sets a High-Stakes 2026 Showdown
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Globus Medical’s Blockbuster Finish Sets a High-Stakes 2026 Showdown
AUDUBON, PA — Globus Medical, Inc. (NYSE: GMED) delivered a powerful year-end surge, posting preliminary fourth-quarter sales of about $823.2 million and capping 2025 with roughly $2.936 billion in revenue, a performance that positions the spine-technology company for another aggressive growth run in 2026. The fourth-quarter figure represents a 25.2 percent jump from a year earlier, while full-year sales climbed 16.5 percent, reflecting strong d…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
